Classifying Pulmonary and Urinary High-grade Neuroendocrine Carcinoma by CK7 Immunohistochemistry. Issue 6 (24th July 2022)

• Record Type: Journal Article
• Authors: Fan, Jiaming; Li, Henry; Zhou, Chen; Xiong, Wei; Villamil, Carlos; Ionescu, Diana; Oo, Htoo Z.; Contreras-Sanz, Alberto; Black, Peter C.; Wang, Gang
• Is Part Of: Applied immunohistochemistry & molecular morphology. Volume 30:Issue 6(2022)
• Page Start: 459
• Page End: 468
• Publication Date: 2022-07-24
• Subjects: small cell carcinoma -- large cell neuroendocrine carcinoma -- cytokeratin 7 -- immunohistochemistry -- staining pattern; Diagnostic immunohistochemistry -- Periodicals; Immunohistochemistry -- Periodicals; Cells -- Morphology -- Periodicals; Molecular diagnosis -- Periodicals; 616.079
• DOI: 10.1097/PAI.0000000000001036
• Languages: English
• ISSNs: 1541-2016

Abstract

Abstract : High-grade neuroendocrine carcinoma (HGNEC) is subclassified into small cell carcinoma (SmCC) and large cell neuroendocrine carcinoma (LCNEC). Although both are clinically aggressive, the SmCC and LCNEC need to have different treatment strategies, and accurate pathologic diagnosis is challenging. We studied a large retrospective cohort (186 cases) of HGNEC of bladder and lung to investigate the abundance of cytokeratin (CK) 7 expression and staining pattern in SmCC and LCNEC. Overall, the pulmonary and urinary HGNEC exhibited several different CK7 staining patterns, including negative staining (n=28), dot-like staining (n=73), partial membranous staining (n=26), and complete membranous staining (n=60). Overall, 88.9% (44/49) of pulmonary SmCC and 88.0% (44/50) of urinary SmCC showed negative or dot-like patterns for CK7, while 90.8% (59/65) of pulmonary LCNEC and 72.7% (16/22) of urinary LCNEC showed partial or complete membranous patterns for CK7 (χ 2 =105.05, P <0.0001). The distinct staining patterns were also present in those mixed SmCC and LCNEC. In addition, the specimen types or fixation did not affect CK7 staining patterns. In conclusion, CK7 has a high differential value for SmCC and LCNEC and could help guide personalized treatment for patients.